Long COVID: rheumatologic/musculoskeletal symptoms in hospitalized COVID-19 survivors at 3 and 6 months.
Fatih KaraarslanFulya Demircioğlu GüneriSinan KardeşPublished in: Clinical rheumatology (2021)
Approximately 3 in 5 patients had at least one symptom with ≈2 in 5 patients had at least one rheumatic and musculoskeletal symptom. Fatigue, joint pain, and myalgia were the most frequent rheumatic and musculoskeletal symptoms. Joint pain and myalgia were mostly widespread. This information guide rheumatologists to understand the nature and features of persistent rheumatic and musculoskeletal symptoms in hospitalized COVID-19 survivors and may contribute to better management of these individuals. Key Points • Approximately 3 in 5 patients had at least one symptom with ≈2 in 5 patients had at least one rheumatic and musculoskeletal symptom at 6 months • Fatigue, joint pain, and myalgia were the most frequent rheumatic and musculoskeletal symptoms followed by back pain, low back pain, and neck pain • Dyspnea, hair loss, and sweat were the most frequent other-COVID-19-symptoms.
Keyphrases
- end stage renal disease
- newly diagnosed
- coronavirus disease
- ejection fraction
- sars cov
- chronic kidney disease
- chronic pain
- rheumatoid arthritis
- peritoneal dialysis
- prognostic factors
- healthcare
- sleep quality
- patient reported
- pain management
- young adults
- depressive symptoms
- neuropathic pain
- respiratory syndrome coronavirus
- postoperative pain